Literature DB >> 11588444

Cardiac troponin I: its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery.

M O Benoit1, M Paris, J Silleran, A Fiemeyer, N Moatti.   

Abstract

OBJECTIVE: To study the value of assaying cardiac troponin I (cTnI) for the early diagnosis of perioperative myocardial infarction (PMI) and various complications of cardiac surgery.
DESIGN: A prospective observational clinical study.
SETTING: Biochemical laboratory, anesthesia, and cardiac surgery department of Hôpital Broussais. PATIENTS: Two hundred and sixty consecutive patients undergoing cardiac surgery.
INTERVENTIONS: All patients underwent coronary artery bypass grafting and/or valvular surgery under extracorporeal circulation. Per-operative and postoperative follow-up consisted of electrocardiogram, echocardiography (mainly by the transesophageal approach), and serial determinations of biochemical markers such as creatinine kinase-MB isoenzyme (CK-MB) and cTnI. PMI, new ST segment changes, and ventricular arrhythmias were considered postoperative adverse cardiac outcome.
MEASUREMENTS AND MAIN RESULTS: CTnI was measured before cardiopulmonary bypass (T0) and 12 and 24 hrs after (T12, T24). CK-MB was measured on arrival in the intensive care unit and on the first postoperative day (D1). Patients were divided into three groups according to the type of surgery: coronary artery bypass graft (CABG), valvular surgery (VS), or both procedures. The plasma CK-MB and cTnI concentrations were high in all patients after extracorporeal circulation because of aortic clamping or cardioplegia. The CK-MB and cTnI values were higher in the VS group than in the CABG group. Values peaked at T12 and fell by T24, except when PMI occurred. Eight patients developed a PMI. Patients with PMI had significantly higher cTnI levels at T12 and T24, and higher CK-MB values at D1 than patients without PMI. Cutoff values of cTnI for diagnosing PMI were >19 microg/L at T12 with 100% sensitivity and 73% specificity, and >36 microg/L at T24, with 100% sensitivity and 93% specificity. Lower cTnI values were highly suggestive of the absence of PMI after CABG and/or VS. Other complications such as ST segment changes, ventricular arrhythmias and cardiac failure were indicated by high cTnI levels at T12 and T24. Myocardial protective measures were associated with a nonsignificant increase in cTnI values.
CONCLUSIONS: CTnI is more sensitive and specific than CK-MB for diagnosing PMI and other forms of heart failure after cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588444     DOI: 10.1097/00003246-200110000-00005

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  14 in total

Review 1.  Periprocedural myocardial enzyme elevation: prognostic implications for current practice.

Authors:  Sanjum S Sethi; Avtar Singh; Michael E Farkouh
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

Review 2.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White
Journal:  Nat Rev Cardiol       Date:  2012-08-25       Impact factor: 32.419

3.  Typical rise and fall of troponin in (peri-procedural) myocardial infarction: A systematic review.

Authors:  Dianne van Beek; Bas van Zaane; Marjolein Looije; Linda Peelen; Wilton van Klei
Journal:  World J Cardiol       Date:  2016-03-26

4.  Age and sex differences in perioperative myocardial infarction after cardiac surgery.

Authors:  Casimiro Javierre; Antoni Ricart; Rafael Manez; Elisabet Farrero; Maria L Carrio; David Rodriguez-Castro; Herminia Torrado; Josep L Ventura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-04-11

5.  Role of alpha-actin in muscle damage of injured athletes in comparison with traditional markers.

Authors:  Antonio Martínez Amat; Juan Antonio Marchal Corrales; Fernando Rodríguez Serrano; Houria Boulaiz; Jose Carlos Prados Salazar; Fidel Hita Contreras; Octavio Caba Perez; Esmeralda Carrillo Delgado; Ignacio Martín; Antonia Aranega Jimenez
Journal:  Br J Sports Med       Date:  2007-02-22       Impact factor: 13.800

6.  Cardioprotection of Shenfu Injection against myocardial ischemia/reperfusion injury in open heart surgery.

Authors:  Chuan-dong Zheng; Su Min
Journal:  Chin J Integr Med       Date:  2008-06-21       Impact factor: 1.978

7.  Troponin testing after cardiac surgery.

Authors:  J L Januzzi
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2009

8.  Plasma levels of microRNA-499 provide an early indication of perioperative myocardial infarction in coronary artery bypass graft patients.

Authors:  Youxiu Yao; Juan Du; Xiaoqing Cao; Yang Wang; Yaohua Huang; Shengshou Hu; Zhe Zheng
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

9.  [Kinetics of cTnI and threshold values for the diagnosis of myocardial infarction after cardiac surgery with cardiopulmonary bypass].

Authors:  Samy Kallel; Anwar Jarraya; Maged Ellouze; Imed Frikha; Abbdelhamid Karoui
Journal:  Pan Afr Med J       Date:  2012-12-29

10.  Is general anesthesia a risk for myocardium? Effect of anesthesia on myocardial function as assessed by cardiac troponin-i in two different groups (isofluran+N2O inhalation and propofol+fentanyl iv anesthesia).

Authors:  Demet Dogan Erol; Ibrahim Ozen
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.